1998
DOI: 10.1007/978-1-4615-4897-3_4
|View full text |Cite
|
Sign up to set email alerts
|

Aminoglycoside Antibiotics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
51
0

Year Published

1999
1999
2019
2019

Publication Types

Select...
5
4

Relationship

3
6

Authors

Journals

citations
Cited by 129 publications
(53 citation statements)
references
References 210 publications
2
51
0
Order By: Relevance
“…6 Aminoglycosides are one class of antibiotics that have been used clinically to treat bacterial infections for over five decades. 7 They interact with many different RNAs, including the hammerhead ribozyme, 8 HIV-1 mRNA, 9-11 tRNA Phe,12 the T box antiterminator RNA, 13 and the 16S bacterial ribosome. 14-16 The binding of aminoglycosides to bacterial ribosomes is of particular interest, since this is believed to be the clinically relevant target site.…”
Section: Introductionmentioning
confidence: 99%
“…6 Aminoglycosides are one class of antibiotics that have been used clinically to treat bacterial infections for over five decades. 7 They interact with many different RNAs, including the hammerhead ribozyme, 8 HIV-1 mRNA, 9-11 tRNA Phe,12 the T box antiterminator RNA, 13 and the 16S bacterial ribosome. 14-16 The binding of aminoglycosides to bacterial ribosomes is of particular interest, since this is believed to be the clinically relevant target site.…”
Section: Introductionmentioning
confidence: 99%
“…The enzymes encoded by these genes modify the structures of antibiotics, such that the modified drugs bind poorly to their targets. Among these antibiotic resistance enzymes, those for aminoglycoside antibiotics are widespread in pathogens (1)(2)(3)(4)(5). Of these enzymes, the aminoglycoside 3Ј-phosphotransferases (APH(3Ј)s) 2 are the most common, and they are responsible for the demise of kanamycin, among other aminoglycosides, as a treatment option.…”
mentioning
confidence: 99%
“…1 below) are widely used in the treatment of bacterial infections caused by both Grampositive and Gram-negative pathogens yet the specific details of the molecular mechanisms of resistance to this class of antibiotics remain largely unknown. Aminoglycosides act first by disrupting protein expression and interfering with translation at the level of appropriate aminoacyl-tRNA recognition at the ribosomal A site; this is followed by a series of secondary effects, including membrane damage, which combine to arrest growth and kill the cell (1). The ribosomal receptor for most aminoglycoside antibiotics, including gentamicin C, kanamycin, and neomycin, is the 16 S rRNA of the 30 S subunit.…”
mentioning
confidence: 99%
“…The aminoglycoside kinases (abbreviated APH) 1 include a number of enzymes with differing aminoglycoside substrate specificities and regiospecificities of phosphoryl transfer. Despite this broad tolerance for aminoglycoside substrates, all APHs share a common active site motif that resembles the active site residues found in the Ser/Thr/Tyr protein kinase superfamily (9).…”
mentioning
confidence: 99%